应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
OMER 奥麦罗制药
休市中 05-01 16:00:00 EDT
15.06
+0.46
+3.15%
盘后
15.11
+0.05
+0.33%
19:44 EDT
最高
15.32
最低
14.45
成交量
128.21万
今开
14.57
昨收
14.60
日振幅
5.96%
总市值
10.84亿
流通市值
10.43亿
总股本
7,200万
成交额
1,916万
换手率
1.85%
流通股本
6,928万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
奥麦罗制药盘中异动 早盘快速上涨5.16%
市场透视 · 02-14
奥麦罗制药盘中异动 早盘快速上涨5.16%
奥麦罗制药盘中异动 大幅上涨5.17%
市场透视 · 02-06
奥麦罗制药盘中异动 大幅上涨5.17%
奥麦罗制药盘中异动 快速下跌5.12%
市场透视 · 01-12
奥麦罗制药盘中异动 快速下跌5.12%
奥麦罗制药盘中异动 快速跳水5.01%报15.56美元
市场透视 · 01-06
奥麦罗制药盘中异动 快速跳水5.01%报15.56美元
美股异动 | YARTEMLEA药物获得FDA批准 奥麦罗制药(OMER.US)暴涨近65%
智通财经 · 2025-12-24
美股异动 | YARTEMLEA药物获得FDA批准 奥麦罗制药(OMER.US)暴涨近65%
奥麦罗制药宣布与诺和诺德达成资产购买及许可协议,涉及其临床阶段Masp-3抑制剂Zaltenibart(Oms906)
美股速递 · 2025-12-01
奥麦罗制药宣布与诺和诺德达成资产购买及许可协议,涉及其临床阶段Masp-3抑制剂Zaltenibart(Oms906)
奥麦罗制药第三季度每股收益为-0.47美元
投资观察 · 2025-11-20
奥麦罗制药第三季度每股收益为-0.47美元
奥麦罗制药盘中异动 早盘股价大涨5.07%报9.54美元
市场透视 · 2025-11-18
奥麦罗制药盘中异动 早盘股价大涨5.07%报9.54美元
奥麦罗制药盘中异动 股价大跌5.09%
市场透视 · 2025-03-10
奥麦罗制药盘中异动 股价大跌5.09%
奥麦罗制药盘中异动 急速跳水5.02%
市场透视 · 2025-03-07
奥麦罗制药盘中异动 急速跳水5.02%
奥麦罗制药盘中异动 临近收盘股价大涨5.01%报8.38美元
市场透视 · 2025-03-06
奥麦罗制药盘中异动 临近收盘股价大涨5.01%报8.38美元
奥麦罗制药盘中异动 早盘股价大跌5.02%报7.76美元
市场透视 · 2025-03-04
奥麦罗制药盘中异动 早盘股价大跌5.02%报7.76美元
奥麦罗制药盘中异动 股价大涨5.56%
市场透视 · 2025-02-26
奥麦罗制药盘中异动 股价大涨5.56%
奥麦罗制药盘中异动 下午盘股价大跌5.01%
市场透视 · 2025-02-25
奥麦罗制药盘中异动 下午盘股价大跌5.01%
奥麦罗制药盘中异动 早盘大幅拉升5.39%报9.00美元
市场透视 · 2025-02-13
奥麦罗制药盘中异动 早盘大幅拉升5.39%报9.00美元
奥麦罗制药盘中异动 股价大涨5.66%
市场透视 · 2025-02-10
奥麦罗制药盘中异动 股价大涨5.66%
奥麦罗制药盘中异动 下午盘急速拉升5.22%
市场透视 · 2025-02-05
奥麦罗制药盘中异动 下午盘急速拉升5.22%
奥麦罗制药盘中异动 股价大涨5.02%报8.79美元
市场透视 · 2025-01-28
奥麦罗制药盘中异动 股价大涨5.02%报8.79美元
奥麦罗制药盘中异动 股价大跌5.11%
市场透视 · 2025-01-25
奥麦罗制药盘中异动 股价大跌5.11%
奥麦罗制药盘中异动 早盘大幅上涨5.17%报9.36美元
市场透视 · 2025-01-16
奥麦罗制药盘中异动 早盘大幅上涨5.17%报9.36美元
加载更多
公司概况
公司名称:
奥麦罗制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Omeros Corporation于1994年在华盛顿成立。该公司正在推进多个开发项目,重点关注与补体系统相关的疾病和紊乱,补体系统是一组专门的蛋白质,可防止侵袭性病原体以及体内受损细胞,是人体免疫系统的重要组成部分。当触发时,补体的各种成分协同产生免疫反应,对抗感染并清除受损或死亡的细胞,维持身体系统的健康功能。然而,补体系统的失调(即过度激活或激活不足)可能是有害的,并且与感染和非感染性疾病的脆弱性增加有关,包括自身免疫性疾病、慢性炎症、血栓性微血管病和癌症。
发行价格:
--
{"stockData":{"symbol":"OMER","market":"US","secType":"STK","nameCN":"奥麦罗制药","latestPrice":15.06,"timestamp":1777665600000,"preClose":14.6,"halted":0,"volume":1282110,"hourTrading":{"tag":"盘后","latestPrice":15.11,"preClose":15.06,"latestTime":"19:44 EDT","volume":15901,"amount":239537.2908,"timestamp":1777679095971,"change":0.05,"changeRate":0.00332,"amplitude":0.015345},"delay":0,"changeRate":0.03150684931506855,"floatShares":69284000,"shares":71996171,"eps":-0.05,"marketStatus":"休市中","change":0.46,"latestTime":"05-01 16:00:00 EDT","open":14.57,"high":15.32,"low":14.4501,"amount":19161636.53712,"amplitude":0.059582,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.05,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1254974400000,"exchange":"NASDAQ","adjPreClose":14.6,"preHourTrading":{"tag":"盘前","latestPrice":14.55,"preClose":14.6,"latestTime":"09:29 EDT","volume":2357,"amount":34605.125164,"timestamp":1777642199999,"change":-0.05,"changeRate":-0.003425,"amplitude":0.021822},"postHourTrading":{"tag":"盘后","latestPrice":15.11,"preClose":15.06,"latestTime":"19:44 EDT","volume":15901,"amount":239537.2908,"timestamp":1777679095971,"change":0.05,"changeRate":0.00332,"amplitude":0.015345},"volumeRatio":0.9671559480651256,"impliedVol":1.0529,"impliedVolPercentile":0.5378},"requestUrl":"/m/hq/s/OMER","defaultTab":"news","newsList":[{"id":"2611193375","title":"奥麦罗制药盘中异动 早盘快速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611193375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611193375?lang=zh_cn&edition=full","pubTime":"2026-02-14 00:05","pubTimestamp":1770998732,"startTime":"0","endTime":"0","summary":"北京时间2026年02月14日00时05分,奥麦罗制药股票出现异动,股价大幅拉升5.16%。截至发稿,该股报12.03美元/股,成交量18.3309万股,换手率0.26%,振幅4.76%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为2.18%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602140005329541162f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602140005329541162f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609540259","title":"奥麦罗制药盘中异动 大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609540259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609540259?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:32","pubTimestamp":1770388341,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日22时32分,奥麦罗制药股票出现波动,股价急速上涨5.17%。截至发稿,该股报11.30美元/股,成交量9.3477万股,换手率0.13%,振幅2.94%。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.56%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223221a4851594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223221a4851594&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602541456","title":"奥麦罗制药盘中异动 快速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602541456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602541456?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:48","pubTimestamp":1768229280,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时48分,奥麦罗制药股票出现波动,股价快速下跌5.12%。截至发稿,该股报11.85美元/股,成交量50.5812万股,换手率0.71%,振幅3.81%。奥麦罗制药股票所在的生物技术行业中,整体跌幅为1.00%。补体靶向治疗药物管线中的候选药物是 narsoplimab ,这是一种专有的专利人单克隆抗体,靶向甘露聚糖结合凝集素相关丝氨酸蛋白酶 2,是补体凝集素途径的关键激活剂。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224801a4bb1b9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224801a4bb1b9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601687848","title":"奥麦罗制药盘中异动 快速跳水5.01%报15.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601687848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601687848?lang=zh_cn&edition=full","pubTime":"2026-01-06 02:10","pubTimestamp":1767636636,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日02时10分,奥麦罗制药股票出现波动,股价快速下挫5.01%。截至发稿,该股报15.56美元/股,成交量140.048万股,换手率1.98%,振幅4.95%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体跌幅为1.67%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106021036a6f6e639&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106021036a6f6e639&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594403267","title":"美股异动 | YARTEMLEA药物获得FDA批准 奥麦罗制药(OMER.US)暴涨近65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594403267","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594403267?lang=zh_cn&edition=full","pubTime":"2025-12-24 23:47","pubTimestamp":1766591240,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周三,奥麦罗制药(OMER.US)暴涨近65%,创年内新高,现报14.38美元。消息面上,该公司宣布,美国食品药品监督管理局(FDA)已批准 YARTEMLEA(纳索普利单抗-wuug)用于治疗造血干细胞移植相关性血栓性微血管病(TA-TMA),这是一种由补体凝集素途径激活引起的、通常会致命的干细胞移植并发症。YARTEMLEA 是首个也是唯一获批的凝集素通路抑制剂。YARTEMLEA 选择性抑制 MASP-2(凝集素途径的效应酶),阻止通路激活,同时保留对宿主防御重要的经典和替代补体功能。YARTEMLEA 获批用于成人以及两岁及以上儿童。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股异动 | YARTEMLEA药物获得FDA批准 奥麦罗制药(OMER.US)暴涨近65%","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175610075","title":"奥麦罗制药宣布与诺和诺德达成资产购买及许可协议,涉及其临床阶段Masp-3抑制剂Zaltenibart(Oms906)","url":"https://stock-news.laohu8.com/highlight/detail?id=1175610075","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175610075?lang=zh_cn&edition=full","pubTime":"2025-12-01 21:32","pubTimestamp":1764595946,"startTime":"0","endTime":"0","summary":"奥麦罗制药宣布与诺和诺德达成资产购买及许可协议,涉及其临床阶段Masp-3抑制剂Zaltenibart(Oms906)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166722527","title":"奥麦罗制药第三季度每股收益为-0.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166722527","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166722527?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:45","pubTimestamp":1763574344,"startTime":"0","endTime":"0","summary":"11月13日 - 奥麦罗制药第三季度净收入为-3090万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584688559","title":"奥麦罗制药盘中异动 早盘股价大涨5.07%报9.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584688559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584688559?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:41","pubTimestamp":1763476860,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时41分,奥麦罗制药股票出现异动,股价快速上涨5.07%。截至发稿,该股报9.54美元/股,成交量28.3136万股,换手率0.40%,振幅6.50%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体跌幅为0.06%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118224100a7022870&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118224100a7022870&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518922076","title":"奥麦罗制药盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518922076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518922076?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:01","pubTimestamp":1741615263,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时01分,奥麦罗制药股票出现异动,股价快速跳水5.09%。截至发稿,该股报7.27美元/股,成交量2.8445万股,换手率0.05%,振幅3.92%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022010396403db7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022010396403db7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517519542","title":"奥麦罗制药盘中异动 急速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517519542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517519542?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:06","pubTimestamp":1741280798,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时06分,奥麦罗制药股票出现波动,股价大幅下跌5.02%。截至发稿,该股报7.94美元/股,成交量12.3756万股,换手率0.21%,振幅3.81%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体跌幅为0.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307010638abeb9d15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307010638abeb9d15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517921874","title":"奥麦罗制药盘中异动 临近收盘股价大涨5.01%报8.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517921874?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:58","pubTimestamp":1741208330,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时58分,奥麦罗制药股票出现波动,股价急速拉升5.01%。截至发稿,该股报8.38美元/股,成交量29.3825万股,换手率0.51%,振幅7.14%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-37.11百万美元,每股收益-0.56美元,毛利-237000.00美元,市盈率-3.64倍。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为1.80%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045851abea1db0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045851abea1db0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516670030","title":"奥麦罗制药盘中异动 早盘股价大跌5.02%报7.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670030?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:43","pubTimestamp":1741099398,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时43分,奥麦罗制药股票出现波动,股价急速下跌5.02%。截至发稿,该股报7.76美元/股,成交量5.702万股,换手率0.10%,振幅2.60%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224318989baf91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224318989baf91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514885985","title":"奥麦罗制药盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514885985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514885985?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580304,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分,奥麦罗制药股票出现异动,股价急速上涨5.56%。截至发稿,该股报8.92美元/股,成交量2.9324万股,换手率0.05%,振幅2.13%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223145abddeca9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223145abddeca9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514703585","title":"奥麦罗制药盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703585?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:23","pubTimestamp":1740428631,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时23分,奥麦罗制药股票出现波动,股价急速下挫5.01%。截至发稿,该股报8.72美元/股,成交量40.3178万股,换手率0.70%,振幅5.12%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体跌幅为0.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225042351a2525e42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225042351a2525e42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511521340","title":"奥麦罗制药盘中异动 早盘大幅拉升5.39%报9.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511521340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511521340?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:20","pubTimestamp":1739460037,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时20分,奥麦罗制药股票出现波动,股价大幅上涨5.39%。截至发稿,该股报9.00美元/股,成交量6.2591万股,换手率0.11%,振幅4.86%。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.涨幅较大,Edesa Biotech, Inc.、Tc Biopharm Plc、Moleculin Biotech, Inc.较为活跃,换手率分别为1971.46%、1125.38%、672.93%,振幅较大的相关个股有Moleculin Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.,振幅分别为376.19%、92.30%、73.65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132320379621c6d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132320379621c6d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510863645","title":"奥麦罗制药盘中异动 股价大涨5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863645?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:38","pubTimestamp":1739198321,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时38分,奥麦罗制药股票出现异动,股价急速拉升5.66%。截至发稿,该股报9.14美元/股,成交量2.196万股,换手率0.04%,振幅3.12%。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃,换手率分别为1836.28%、995.10%、677.43%,振幅较大的相关个股有Soligenix, Inc.、Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.,振幅分别为103.16%、42.01%、34.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223842961e01a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223842961e01a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509936464","title":"奥麦罗制药盘中异动 下午盘急速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509936464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509936464?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:06","pubTimestamp":1738695984,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时06分,奥麦罗制药股票出现异动,股价快速拉升5.22%。截至发稿,该股报8.87美元/股,成交量37.6298万股,换手率0.65%,振幅5.58%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为1.37%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205030624961801cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205030624961801cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506058886","title":"奥麦罗制药盘中异动 股价大涨5.02%报8.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506058886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506058886?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:32","pubTimestamp":1737999155,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时32分,奥麦罗制药股票出现异动,股价快速拉升5.02%。截至发稿,该股报8.79美元/股,成交量21.7297万股,换手率0.37%,振幅7.41%。奥麦罗制药股票所在的生物技术行业中,整体涨幅为1.11%。其相关个股中,Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大,Onconetix, Inc.、Allarity Therapeutics, Inc.、Evaxion Biotech As较为活跃,换手率分别为2104.86%、249.05%、236.08%,振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immatics N V C/Wts 01/07/2025 ,振幅分别为85.35%、65.16%、61.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128013235abba8506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128013235abba8506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506827898","title":"奥麦罗制药盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506827898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506827898?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:24","pubTimestamp":1737735854,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时24分,奥麦罗制药股票出现异动,股价大幅跳水5.11%。截至发稿,该股报8.55美元/股,成交量15.383万股,换手率0.27%,振幅5.99%。奥麦罗制药股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Evaxion Biotech As、Pmgc Holdings Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大,Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为3869.75%、2100.35%、1560.66%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Windtree Therapeutics, Inc.,振幅分别为134.08%、112.09%、66.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002414abb768d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002414abb768d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503919374","title":"奥麦罗制药盘中异动 早盘大幅上涨5.17%报9.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503919374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503919374?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:20","pubTimestamp":1737040803,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时20分,奥麦罗制药股票出现异动,股价大幅拉升5.17%。截至发稿,该股报9.36美元/股,成交量17.7074万股,换手率0.31%,振幅5.96%。奥麦罗制药股票所在的生物技术行业中,整体跌幅为0.80%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Aditxt, Inc.、Palisade Bio, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为1725.62%、362.64%、240.74%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aditxt, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为131.33%、61.60%、56.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116232004abad5b6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116232004abad5b6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.omeros.com","stockEarnings":[{"period":"1week","weight":0.1131},{"period":"1month","weight":0.2467},{"period":"3month","weight":0.2883},{"period":"6month","weight":1.0546},{"period":"1year","weight":1.1453},{"period":"ytd","weight":-0.1231}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Omeros Corporation于1994年在华盛顿成立。该公司正在推进多个开发项目,重点关注与补体系统相关的疾病和紊乱,补体系统是一组专门的蛋白质,可防止侵袭性病原体以及体内受损细胞,是人体免疫系统的重要组成部分。当触发时,补体的各种成分协同产生免疫反应,对抗感染并清除受损或死亡的细胞,维持身体系统的健康功能。然而,补体系统的失调(即过度激活或激活不足)可能是有害的,并且与感染和非感染性疾病的脆弱性增加有关,包括自身免疫性疾病、慢性炎症、血栓性微血管病和癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.352941,"avgChangeRate":-0.012739},{"month":2,"riseRate":0.588235,"avgChangeRate":0.056959},{"month":3,"riseRate":0.588235,"avgChangeRate":0.084424},{"month":4,"riseRate":0.411765,"avgChangeRate":-0.00729},{"month":5,"riseRate":0.411765,"avgChangeRate":-0.028683},{"month":6,"riseRate":0.3125,"avgChangeRate":0.036171},{"month":7,"riseRate":0.4375,"avgChangeRate":0.065457},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.029297},{"month":9,"riseRate":0.3125,"avgChangeRate":-0.001727},{"month":10,"riseRate":0.5,"avgChangeRate":-0.042054},{"month":11,"riseRate":0.647059,"avgChangeRate":0.236058},{"month":12,"riseRate":0.529412,"avgChangeRate":0.065706}],"exchange":"NASDAQ","name":"奥麦罗制药","nameEN":"Omeros"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥麦罗制药(OMER)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥麦罗制药(OMER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥麦罗制药,OMER,奥麦罗制药股票,奥麦罗制药股票老虎,奥麦罗制药股票老虎国际,奥麦罗制药行情,奥麦罗制药股票行情,奥麦罗制药股价,奥麦罗制药股市,奥麦罗制药股票价格,奥麦罗制药股票交易,奥麦罗制药股票购买,奥麦罗制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥麦罗制药(OMER)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥麦罗制药(OMER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}